Cargando…
Reduced discomfort during high-definition transcutaneous stimulation using 6% benzocaine
Background: High-Definition transcranial Direct Current Stimulation (HD-tDCS) allows for non-invasive neuromodulation using an array of compact (approximately 1 cm(2) contact area) “High-Definition” (HD) electrodes, as compared to conventional tDCS (which uses two large pads that are approximately 3...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093654/ https://www.ncbi.nlm.nih.gov/pubmed/25071548 http://dx.doi.org/10.3389/fneng.2014.00028 |
_version_ | 1782325766012272640 |
---|---|
author | Guleyupoglu, Berkan Febles, Nicole Minhas, Preet Hahn, Christoph Bikson, Marom |
author_facet | Guleyupoglu, Berkan Febles, Nicole Minhas, Preet Hahn, Christoph Bikson, Marom |
author_sort | Guleyupoglu, Berkan |
collection | PubMed |
description | Background: High-Definition transcranial Direct Current Stimulation (HD-tDCS) allows for non-invasive neuromodulation using an array of compact (approximately 1 cm(2) contact area) “High-Definition” (HD) electrodes, as compared to conventional tDCS (which uses two large pads that are approximately 35 cm(2)). In a previous transcutaneous study, we developed and validated designs for HD electrodes that reduce discomfort over >20 min session with 2 mA electrode current. Objective: The purpose of this study was to investigate the use of a chemical pretreatment with 6% benzocaine (topical numbing agent) to further reduce subjective discomfort during transcutaneous stimulation and to allow for better sham controlled studies. Methods: Pre-treatment with 6% benzocaine was compared with control (no pretreatment) for 22 min 2 mA of stimulation, with either CCNY-4 or Lectron II electroconductive gel, for both cathodal and anodal transcutaneous (forearm) stimulation (eight different combinations). Results: Results show that for all conditions and polarities tested, stimulation with HD electrodes is safe and well tolerated and that pretreatment further reduced subjective discomfort. Conclusion: Pretreatment with a mild analgesic reduces discomfort during HD-tDCS. |
format | Online Article Text |
id | pubmed-4093654 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-40936542014-07-28 Reduced discomfort during high-definition transcutaneous stimulation using 6% benzocaine Guleyupoglu, Berkan Febles, Nicole Minhas, Preet Hahn, Christoph Bikson, Marom Front Neuroeng Neuroscience Background: High-Definition transcranial Direct Current Stimulation (HD-tDCS) allows for non-invasive neuromodulation using an array of compact (approximately 1 cm(2) contact area) “High-Definition” (HD) electrodes, as compared to conventional tDCS (which uses two large pads that are approximately 35 cm(2)). In a previous transcutaneous study, we developed and validated designs for HD electrodes that reduce discomfort over >20 min session with 2 mA electrode current. Objective: The purpose of this study was to investigate the use of a chemical pretreatment with 6% benzocaine (topical numbing agent) to further reduce subjective discomfort during transcutaneous stimulation and to allow for better sham controlled studies. Methods: Pre-treatment with 6% benzocaine was compared with control (no pretreatment) for 22 min 2 mA of stimulation, with either CCNY-4 or Lectron II electroconductive gel, for both cathodal and anodal transcutaneous (forearm) stimulation (eight different combinations). Results: Results show that for all conditions and polarities tested, stimulation with HD electrodes is safe and well tolerated and that pretreatment further reduced subjective discomfort. Conclusion: Pretreatment with a mild analgesic reduces discomfort during HD-tDCS. Frontiers Media S.A. 2014-07-11 /pmc/articles/PMC4093654/ /pubmed/25071548 http://dx.doi.org/10.3389/fneng.2014.00028 Text en Copyright © 2014 Guleyupoglu, Febles, Minhas, Hahn and Bikson. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Guleyupoglu, Berkan Febles, Nicole Minhas, Preet Hahn, Christoph Bikson, Marom Reduced discomfort during high-definition transcutaneous stimulation using 6% benzocaine |
title | Reduced discomfort during high-definition transcutaneous stimulation using 6% benzocaine |
title_full | Reduced discomfort during high-definition transcutaneous stimulation using 6% benzocaine |
title_fullStr | Reduced discomfort during high-definition transcutaneous stimulation using 6% benzocaine |
title_full_unstemmed | Reduced discomfort during high-definition transcutaneous stimulation using 6% benzocaine |
title_short | Reduced discomfort during high-definition transcutaneous stimulation using 6% benzocaine |
title_sort | reduced discomfort during high-definition transcutaneous stimulation using 6% benzocaine |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093654/ https://www.ncbi.nlm.nih.gov/pubmed/25071548 http://dx.doi.org/10.3389/fneng.2014.00028 |
work_keys_str_mv | AT guleyupogluberkan reduceddiscomfortduringhighdefinitiontranscutaneousstimulationusing6benzocaine AT feblesnicole reduceddiscomfortduringhighdefinitiontranscutaneousstimulationusing6benzocaine AT minhaspreet reduceddiscomfortduringhighdefinitiontranscutaneousstimulationusing6benzocaine AT hahnchristoph reduceddiscomfortduringhighdefinitiontranscutaneousstimulationusing6benzocaine AT biksonmarom reduceddiscomfortduringhighdefinitiontranscutaneousstimulationusing6benzocaine |